Our results demonstrated that BRCA patients with high expression of CDKN2A exhibited an increased infiltration level of most immune cells in BRCA, including activated dendritic cells, M0 macrophages, activated NK cells, activated memory CD4 + T cells, CD8 + T cells, follicular helper T cells, and regulatory T cells (Figure 2H). Here, CD4 is linked to invasive breast carcinoma.